Maria Charlotte Fribert
Chief Executive Officer chez TOLERANZIA AB
Profil
Maria Charlotte Fribert is the founder of Epixis SA. She is currently the Chief Executive Officer at Toleranzia AB since 2016.
Previously, she worked at AstraZeneca R&D Mölndal as a Project Director-Drug Development.
Dr. Fribert holds a doctorate degree from Université Pierre et Marie Curie.
Postes actifs de Maria Charlotte Fribert
| Sociétés | Poste | Début |
|---|---|---|
| TOLERANZIA AB | Chief Executive Officer | 11/04/2016 |
Anciens postes connus de Maria Charlotte Fribert
| Sociétés | Poste | Fin |
|---|---|---|
Epixis SA
 Epixis SA BiotechnologyHealth Technology Epixis SA is a biotechnology company that develops platform for preventive and therapeutic vaccines based on VLPs ('virus-like particles'). It manufactures seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as Human papillomavirus (HPV) or Human immunodeficiency virus (HIV). The company was incorporated in 2003 and is headquartered in Paris, Frace. | Founder | - |
| AstraZeneca R&D Mölndal | Corporate Officer/Principal | - |
Formation de Maria Charlotte Fribert
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TOLERANZIA AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Université Pierre et Marie Curie | Consumer Services |
Epixis SA
Epixis SA BiotechnologyHealth Technology Epixis SA is a biotechnology company that develops platform for preventive and therapeutic vaccines based on VLPs ('virus-like particles'). It manufactures seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as Human papillomavirus (HPV) or Human immunodeficiency virus (HIV). The company was incorporated in 2003 and is headquartered in Paris, Frace. | Health Technology |
| AstraZeneca R&D Mölndal |
